Scapa Group plc announced the following directorate changes. Mr. Pierre Guyot will join the Board as an Independent Non-Executive Director, effective January 8, 2018, and will also become a member of the Board's Audit and Risk, Remuneration, and Nominations Committees upon his appointment. Mr. Guyot has over 30 years' experience in the international healthcare industry and is currently a Director of Permobil AB, Sweden, and Peters Surgical SA, France. From January 2014 until 31 December 2017, Mr. Guyot was a Director of Spineguard SA, France, and from 2007 to 2014, he was the Chief Executive Officer of Mölnlycke Health Care in Sweden. Prior to this, Mr. Guyot served in various roles in sales and marketing and EMEA positions with Becton Dickinson, Johnson & Johnson, and Boston Scientific. Mr. Brendan McAtamney will join the Board as an Independent Non-Executive Director with effect from 1 February 2018, and will also become a member of the Board's Audit and Risk, Remuneration and Nominations Committees with effect from that date. Mr. McAtamney was appointed Chief Executive Officer of UDG Healthcare on 2 February 2016, having served as an executive director since December 2013, and having originally joined UDG as Chief Operating Officer in 2013. Prior to that, Mr. McAtamney has held various senior management positions with Abbott, latterly as Vice President Commercial and Corporate Officer within its Established Pharmaceuticals Division. Mr. Richard Perry, Senior Independent Non-Executive Director, who having served on the Board since 2005, has indicated that he does not intend to offer himself for re-election at the 2018 AGM.